Diffuse large B-cell lymphoma trials in Mexico

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  Mexico City, Monterrey, Morelia, Oaxaca City, Pachuca, Torreón

  Age

  18 years and over

  People

  1,046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• Phase 2/3Taking people
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  Chihuahua City, Mexico City

  Age

  18 years and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00
• Phase 2Taking people
  Low Dose Epcoritamab Plus GemOx in R/R DLBCL

  Where

  Monterrey

  Age

  18 years to 65 years

  People

  10

  Run by

  Hospital Universitario Dr. Jose E. Gonzalez

  See details and how to joinNCT07451652
• No phaseTaking people
  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Where

  Huixquilucan de Degollado, Mexico City

  Age

  18 years and over

  People

  700 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06830759